(VIANEWS) - Verra Mobility Corporation (VRRM), Gentherm (THRM), Equity Bancshares (EQBK) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Verra Mobility Corporation (VRRM)
23% sales growth and 20.67% return on equity
Verra Mobility Corporation offers smart mobility solutions and services throughout the United States and Canada.
Verra Mobility Corporation's sales growth this year is expected to be 30.3% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 89.6%, now sitting on 631.12M for the twelve trailing months.
Volume
Today's last reported volume for Verra Mobility Corporation is 1593720 which is 73.11% above its average volume of 920638.
Verra Mobility Corporation's sales growth for the next quarter is 23%. The company's growth estimates for the current quarter and the next is 150% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 20.67%.
Volatility
Verra Mobility Corporation's last day, last week, and last month's current intraday variation average was 2.19%, 1.91%, and 1.24%, respectively.
Verra Mobility Corporation's highest amplitude of average volatility was 3.62% (day), 3.68% (last week), and 3.37% (last month), respectively.
Verra Mobility Corporation's Stock Yearly Top and Bottom Value
Verra Mobility Corporation's stock is valued at $15.43 at 11:22 EST, way below its 52-week high of $18.13 and way above its 52-week low of $12.70.
Verra Mobility Corporation's Moving Average
Verra Mobility Corporation's worth is higher than its 50-day moving average of $15.10 and below its 200-day moving average of $15.44.2. Gentherm (THRM)
19.2% sales growth and 11.39% return on equity
Gentherm Incorporated develops, produces, markets, and maintains thermal management technology.
Gentherm's sales growth this year is expected to be 9.4% and 20.3% for next year.
Year-on-year quarterly revenue growth declined by 7.2%, now sitting on 1.03B for the twelve trailing months.
Volume
Today's last reported volume for Gentherm is 6767 which is 96.12% below its average volume of 174796.
Gentherm's sales growth for the next quarter is 19.2%. The company's growth estimates for the current quarter and the next is a negative 49.4% and 68.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.39%.
Volatility
Gentherm's last day, last week, and last month's current intraday variation average was 0.27%, 2.76%, and 3.01%, respectively.
Gentherm's highest amplitude of average volatility was 2.80% (day), 5.18% (last week), and 4.67% (last month), respectively.
Gentherm's Stock Yearly Top and Bottom Value
Gentherm's stock is valued at $66.79 at 11:22 EST, way below its 52-week high of $99.00 and way above its 52-week low of $57.79.
Gentherm's Moving Average
Gentherm's worth is under its 50-day moving average of $67.02 and way below its 200-day moving average of $78.73.3. Equity Bancshares (EQBK)
19.1% sales growth and 12.49% return on equity
Equity Bancshares, Inc. is the bank holding firm for Equity Bank. It provides financial services, including mortgage banking, to individuals and corporations.
Equity Bancshares's sales growth this year is anticipated to be 8.7% and 6.3% for next year.
Year-on-year quarterly revenue growth grew by 10%, now sitting on 187.79M for the twelve trailing months.
Volume
Today's last reported volume for Equity Bancshares is 33707 which is 34.63% below its average volume of 51569.
Equity Bancshares's sales growth for the next quarter is 19.1%. The company's growth estimates for the ongoing quarter and the next is a negative 30.1% and negative -6.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.49%.
Volatility
Equity Bancshares's last day, last week, and last month's current intraday variation average was 2.11%, 1.80%, and 1.39%, respectively.
Equity Bancshares's highest amplitude of average volatility was 2.28% (day), 2.20% (last week), and 2.17% (last month), respectively.
Equity Bancshares's Stock Yearly Top and Bottom Value
Equity Bancshares's stock is valued at $29.84 at 11:22 EST, way below its 52-week high of $36.00 and above its 52-week low of $28.01.
Equity Bancshares's Moving Average
Equity Bancshares's worth is under its 50-day moving average of $31.61 and below its 200-day moving average of $32.64.4. Charles River Laboratories (CRL)
17.6% sales growth and 18.37% return on equity
Charles River Laboratories International, Inc. is an early-stage contract-research company that provides services for drug discovery, safety testing, and non-clinical research.
Charles River Laboratories's sales growth this year is anticipated to be 22.2% and 11.9% for next year.
Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 3.43B for the twelve trailing months.
Volume
Today's last reported volume for Charles River Laboratories is 158542 which is 71.13% below its average volume of 549222.
Charles River Laboratories's sales growth for the next quarter is 17.6%. The company's growth estimates for the current quarter and the next is 10.7% and 7.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.37%.
Volatility
Charles River Laboratories's last day, last week, and last month's current intraday variation average was 0.90%, 1.90%, and 2.06%, respectively.
Charles River Laboratories's highest amplitude of average volatility was 3.09% (day), 3.33% (last week), and 3.30% (last month), respectively.
Charles River Laboratories's Stock Yearly Top and Bottom Value
Charles River Laboratories's stock is valued at $214.72 at 11:22 EST, under its 52-week low of $237.27.
Charles River Laboratories's Moving Average
Charles River Laboratories's value is way below its 50-day moving average of $393.86 and way under its 200-day moving average of $371.52.5. Medallion Financial Corp. (MFIN)
14% sales growth and 17.46% return on equity
Medallion Financial Corp. and its affiliates operate in the United States as a financial company.
Medallion Financial Corp.'s sales growth this year is expected to be 18.7% and 23.1% for next year.
Year-on-year quarterly revenue growth grew by 39.8%, now sitting on 191.5M for the twelve trailing months.
Volume
Today's last reported volume for Medallion Financial Corp. is 54315 which is 48.84% below its average volume of 106173.
Medallion Financial Corp.'s sales growth is a negative 0% for the ongoing quarter and 14% for the next. The company's growth estimates for the current quarter and the next is a negative 24.4% and negative -43.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.46%.
Volatility
Medallion Financial Corp.'s last day, last week, and last month's current intraday variation average was 0.42%, 2.51%, and 1.69%, respectively.
Medallion Financial Corp.'s highest amplitude of average volatility was 2.27% (day), 4.87% (last week), and 4.34% (last month), respectively.
Medallion Financial Corp.'s Stock Yearly Top and Bottom Value
Medallion Financial Corp.'s stock is valued at $7.07 at 11:22 EST, way under its 52-week high of $10.05 and way higher than its 52-week low of $3.50.
Medallion Financial Corp.'s Moving Average
Medallion Financial Corp.'s worth is under its 50-day moving average of $7.85 and way below its 200-day moving average of $8.00.6. STARWOOD PROPERTY TRUST (STWD)
12.2% sales growth and 12.82% return on equity
Starwood Property Trust, Inc. is a real-estate investment trust (REIT), in both the United States of America and Europe.
STARWOOD PROPERTY TRUST's sales growth this year is expected to be 13.6% and 16.7% for next year.
Year-on-year quarterly revenue growth declined by 7%, now sitting on 704.45M for the twelve trailing months.
Volume
Today's last reported volume for STARWOOD PROPERTY TRUST is 854202 which is 64.57% below its average volume of 2411120.
STARWOOD PROPERTY TRUST's sales growth for the next quarter is 12.2%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and 1.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.82%.
Volatility
STARWOOD PROPERTY TRUST's last day, last week, and last month's current intraday variation average was 2.84%, 3.28%, and 1.88%, respectively.
STARWOOD PROPERTY TRUST's highest amplitude of average volatility was 2.57% (day), 3.93% (last week), and 2.65% (last month), respectively.
STARWOOD PROPERTY TRUST's Stock Yearly Top and Bottom Value
STARWOOD PROPERTY TRUST's stock is valued at $20.98 at 11:22 EST, way below its 52-week high of $27.01 and higher than its 52-week low of $19.69.
STARWOOD PROPERTY TRUST's Moving Average
STARWOOD PROPERTY TRUST's value is below its 50-day moving average of $23.09 and way below its 200-day moving average of $24.32.7. U.S. Physical Therapy (USPH)
11.4% sales growth and 13.43% return on equity
U.S. U.S.
U.S. Physical Therapy's sales growth this year is expected to be 12.6% and 5.7% for next year.
Year-on-year quarterly revenue growth grew by 10.5%, now sitting on 489.72M for the twelve trailing months.
Volume
Today's last reported volume for U.S. Physical Therapy is 46986 which is 32.98% below its average volume of 70108.
U.S. Physical Therapy's sales growth for the next quarter is 11.4%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and 3.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.43%.
Volatility
U.S. Physical Therapy's last day, last week, and last month's current intraday variation average was 1.76%, 1.49%, and 1.68%, respectively.
U.S. Physical Therapy's highest amplitude of average volatility was 2.21% (day), 2.83% (last week), and 2.96% (last month), respectively.
U.S. Physical Therapy's Stock Yearly Top and Bottom Value
U.S. Physical Therapy's stock is valued at $107.85 at 11:22 EST, way below its 52-week high of $123.38 and way above its 52-week low of $84.43.
U.S. Physical Therapy's Moving Average
U.S. Physical Therapy's value is higher than its 50-day moving average of $106.19 and higher than its 200-day moving average of $101.56.8. ProLogis (PLD)
6.6% sales growth and 4.62% return on equity
Prologis, Inc., is a global leader in logistics real property with a special focus on high growth, high-barrier markets.
ProLogis's sales growth this year is expected to be 8.7% and 7.1% for next year.
Year-on-year quarterly revenue growth declined by 7.3%, now sitting on 4.79B for the twelve trailing months.
Volume
Today's last reported volume for ProLogis is 903683 which is 81.13% below its average volume of 4790510.
ProLogis's sales growth for the next quarter is 6.6%. The company's growth estimates for the present quarter and the next is 30% and 42.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.62%.
Volatility
ProLogis's last day, last week, and last month's current intraday variation average was 0.55%, 1.04%, and 2.24%, respectively.
ProLogis's highest amplitude of average volatility was 2.18% (day), 2.90% (last week), and 3.47% (last month), respectively.
ProLogis's Stock Yearly Top and Bottom Value
ProLogis's stock is valued at $116.30 at 11:22 EST, way below its 52-week high of $161.11 and way above its 52-week low of $93.08.